Showing results (401-410 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|August 8, 2020
ROS1-dependent cancers - biology, diagnostics and therapeuticsAlexander Drilon, Chelsea Jenkins, Sudarshan Iyer, et al.Nature Reviews. Clinical Oncology|July 9, 2020
Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigmCaroline Robert, Aurelien Marabelle, Hugo Herrscher, et al.Nature Reviews. Clinical Oncology|April 9, 2021
Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomesZowi R Huinen, Elisabeth J M Huijbers, Judy R van Beijnum, et al.Nature Reviews. Clinical Oncology|April 1, 2009
Is it time to consider a role for MRI before prostate biopsy?Hashim U Ahmed, Alex Kirkham, Manit Arya, et al.Nature Reviews. Clinical Oncology|April 1, 2009
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapyFrancesco Torino, Salvatore Maria Corsello, Raffaele Longo, et al.Nature Reviews. Clinical Oncology|August 31, 2022
Senescence and cancer - role and therapeutic opportunitiesClemens A Schmitt, Boshi Wang, Marco DemariaNature Reviews. Clinical Oncology|February 29, 2024
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directionsMasuko Katoh, Yohann Loriot, Giovanni Brandi, et al.Nature Reviews. Clinical Oncology|November 9, 2023
Progress in systemic therapy for advanced-stage urothelial carcinomaRosa Nadal, Begoña P Valderrama, Joaquim BellmuntNature Reviews. Clinical Oncology|July 22, 2024
HER2-targeted therapies beyond breast cancer - an updateJeesun Yoon, Do-Youn OhNature Reviews. Clinical Oncology|May 31, 2024
Bispecific and multispecific antibodies in oncology: opportunities and challengesMaria-Elisabeth Goebeler, Gernot Stuhler, Ralf BargouPageof 97